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Summary
In lower or simple species, such as worms and flies, disruption of
the insulin-like growth factor (IGF)-1 and the insulin signaling
pathways has been shown to increase lifespan. In rodents,
however, growth hormone (GH) regulates IGF-1 levels in serum
and tissues and can modulate lifespan via/or independent of IGF-
1. Rodent models, where the GH/IGF-1 axis was ablated congen-
itally, show increased lifespan. However, in contrast to rodents
where serum IGF-1 levels are high throughout life, in humans,
serum IGF-1 peaks during puberty and declines thereafter during
aging. Thus, animal models with congenital disruption of the GH/
IGF-1 axis are unable to clearly distinguish between develop-
mental and age-related effects of GH/IGF-1 on health. To
overcome this caveat, we developed an inducible liver IGF-1-
deficient (iLID) mouse that allows temporal control of serum IGF-
1. Deletion of liver Igf -1 gene at one year of age reduced serum
IGF-1 by 70% and dramatically impaired health span of the iLID
mice. Reductions in serum IGF-1 were coupled with increased GH
levels and increased basal STAT5B phosphorylation in livers of
iLID mice. These changes were associated with increased liver
weight, increased liver inflammation, increased oxidative stress
in liver and muscle, and increased incidence of hepatic tumors.
Lastly, despite elevations in serum GH, low levels of serum IGF-1
from 1 year of age compromised skeletal integrity and acceler-
ated bone loss. We conclude that an intact GH/IGF-1 axis is
essential to maintain health span and that elevated GH, even late
in life, associates with increased pathology.
Key words: aging; bone; growth hormone; IGF; insulin-
sensitivity; LID; lifespan; liver; tumor.
Introduction
The role of growth hormone (GH)/insulin-like growth factor-1 (IGF-1)
axis in lifespan has been studied in detail along the evolutionary lineage.
Disruption of insulin/IGF-like signaling in yeast, worms, and flies has been
conclusively shown to increase lifespan. In these lower order species,
insulin and IGF-1 axis exists as a single axis. However, in rodents and
other mammalian species, the insulin and IGF-1 axes are complex and
distinct even though they share homology. In mammals, GH regulates
serum IGF-1 levels, and while the insulin axis predominantly influences
metabolism, the GH/IGF-1 axis is concerned with cell survival and
growth.
The evidence for the role of IGF-1 in health/lifespan in primates is
even less conclusive (Colman et al., 2009; Mattison et al., 2012; Stein
et al., 2012). In humans, serum GH concentrations and GH secretion
rates fall in adulthood, accompanied by a gradual fall in plasma IGF-1
concentrations, a state often termed the somatopause. In humans,
reductions in IGF-1 also associate with higher incidence of diabetes
(Barzilai et al., 2012), osteoporosis (Lombardi et al., 2005), dementia,
and Alzheimer disease (O’Neill et al., 2012). Decline in GH/IGF-1 axis has
been also shown to be associated with decreased incidence of tumors
(Bartke et al., 2013). Indeed, human subjects with mutations in the GHR
(Laron dwarfs) who show congenital IGF-1 deficiency do not exhibit
increases in lifespan, but show protection from development of
malignancies and diabetes when compared to their healthy siblings
(Laron, 2005; Guevara-Aguirre et al., 2011).
Rodent models where global IGF-1 is decreased, such as caloric
restriction (Wolf et al., 2000; Ward et al., 2005), and GH receptor
deletion in mice (Hauck & Bartke, 2000; Westbrook et al., 2009) show
increased lifespan. On the other hand, mice overexpressing GH
throughout their lifespan live shorter (Bartke et al., 2002; Sonntag
et al., 2012). Although the aforementioned studies point to a simple
cause and effect relationship between the GH/IGF-1 axis and lifespan,
experiments in many rodent models point to more complex interactions.
The latter may depend on species, genetic background, gender, or even
husbandry conditions. For example; female mice with igf-1 receptor (igfr)
haploinsufficiency lived longer than control females in one study
(Holzenberger et al., 2003), but when repeated, the effect was smaller
(Bokov et al., 2011). In addition to these studies, a brain-specific
knockout of the Igf-1r was associated with increased median lifespan.
However, these animals also show reduced GH levels, and thus, the
effects of the Igf-1r deficiency cannot be distinguished from those of
reduced GH levels (Kappeler et al., 2008). Furthermore, animal models
in which components of the IGF-1 receptor signaling pathway were
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ablated, exhibit no change, or even reduced lifespan (Taguchi et al.,
2007; Selman et al., 2008) as compared to controls.
While studies in rodents provide significant insights into the GH/IGF
system and its role in aging, interpretations of the observations are
complicated due to (i) developmental effects secondary to loss of the
GH/IGF axis during crucial phases of growth and development and (ii)
difficulties in distinguishing effects of serum IGF-1 from tissue IGF-1, and
those arising from secondary increases in GH.
To better address how decline in serum IGF-1 affects aging, we used
two mouse models: (i) congenital liver IGF-1-deficient (LID) mice, where
serum IGF-1 is low throughout lifespan, and (ii) an inducible liver Igf1
gene-deleted (iLID) mouse model (Wu et al., 2010; Courtland et al.,
2011), which allows temporal control of IGF-1. The iLID mice express the
Cre recombinase under the liver-specific ET (tamoxifen-inducible)-a1-
antitrypsin promoter, and induction of the Cre recombinase was
achieved by a single intraperitoneal injection of tamoxifen.
Using the congenital LID cohort, we performed survival studies and
end-of-life pathology. Using the iLID model, we depleted serum IGF-1
levels when mice reached 1 year of age and followed them up to 2 years
of age. Unfortunately, we did not perform survival studies in the iLID
cohort, but at 2 years, we studied inflammation, oxidative stress
resistance, tumor incidence, and bone loss.
Results
Congenital decreases in serum IGF-1 impair lifespan in male
mice
To understand how reductions in serum IGF-1 levels affect overall
lifespan, we used the LID mouse model, where the Cre recombinase was
expressed under the albumin promoter, specifically in the liver (Yakar
et al., 1999). LID mice show early postnatal gene recombination (1 week
old) and exhibit reductions in serum IGF-1 levels throughout life with
concomitant increases in serum GH levels. Male and female (control and
LID) mice were aged in the Nathan Shock Center at Texas Health Science
Center, San Antonio (UTHSCSA). We observed robust longevity in both
control male (median lifespan of 34.7  1.3 months) and control female
(median lifespan of 34.8  1.0 months) mice. The overall survival, as
analyzed by the log-rank test, was similar in female LID (with median
lifespan of 36.2  1.2 months). In contrast, overall survival of male LID
mice was 27.9  1.7 months, which was statistically significantly lower
(P = 0.006) than the other groups (Fig. 1A, Table S1). Male LID mice
showed decreased body weight throughout life (Fig. 1B) with similar
food intake (Fig. 1C) when compared to controls.
Tissues dissected from a subcohort of male LID and control mice at
19-20 months of age (Table S2) revealed significant increases in
absolute and relative liver weight in LID mice. Additionally, we found
that absolute and relative kidney weight and quadriceps weight were
significantly reduced in LID mice when compared to controls.
The probable causes of death for the LID and control groups are
shown in Table 1. Approximately 22% of male control and 55% of
female control mice died from neoplastic diseases. The major fatal
neoplastic diseases observed in these control mice were hepatocellular
carcinoma (HCC), pulmonary adenocarcinoma, and pituitary adenoma
(female mice only). In addition, the neoplastic diseases were usually
associated with metastasis to the other organs or other pathological
lesions, for example pleural effusion, ascites, hemorrhage in the pleural
and/or abdominal cavities, and severe congestion and edema in the lung.
Male LID mice showed a higher incidence of fatal neoplasms (approx-
imately 69%) than their control mice, although the changes in incidence
were not statistically significant. The incidence of fatal HCC was
significantly higher in male LID mice (approximately 69%) than the
control group (5.6%; P < 0.05). The female LID mice showed a similar
incidence of fatal neoplasms compared with their control mice.
Although the incidence of fatal HCC was slightly higher in female LID
Fig. 1 Kaplan–Meier product limit estimates of the survival curves of male and
female control and LID mice. (A) Female LID mice (n = 17) show no significant
difference in the survival from female controls (n = 25). However, LID males
(n = 16) live shorter than male controls (n = 15), P = 0.006; quantile regression
indicates that most of the effect occurs in first half of lifespan; means are
significantly different. (B) Body weight and (C) food intake in male mice
determined at 2 weeks intervals.
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mice (approximately 24%) than in the control group (4.5%), the
difference was not statistically significant. The major fatal non-neoplastic
diseases observed in these mice were glomerulonephritis, thrombus in
heart, hydronephrosis, and acidophilic macrophage pneumonia. These
lesions were usually associated with other pathological lesions, for
example pleural effusion, ascites, and/or severe congestion and edema in
the lung. The incidence of fatal glomerulonephritis was slightly lower in
both male and female LID mice than in the control group; however, the
difference was not statistically significant.
The described studies with the LID model indicated that lifelong
reductions in serum IGF-1 levels impaired health span mainly in male
mice and coincided with hepatomegaly, decreased muscle and kidney
weight, and increased HCC. However, one limitation of the LID mouse
model is lifelong reductions in serum IGF-1; thus, the true impact of
serum IGF-1 reductions after sexual maturation, during adulthood,
remained unclear. To understand how reductions in serum IGF-1
during adulthood affect aging, we developed an inducible LID (iLID)
model.
Generation of a mouse model with age-dependent
reductions in serum IGF-1 levels
Generation of the iLID mice, described earlier (Wu et al., 2010;
Courtland et al., 2011), was achieved by crossing mice homozygous
for the floxed Igf-1 allele with mice expressing the Cre recombinase
under the tamoxifen-inducible antitrypsin 1-a promoter specifically in the
liver. Control mice were homozygous for the floxed Igf-1 allele but did
not carry the Cre transgene. Ablation of hepatic Igf-1 gene was induced
in iLID mice by a single intraperitoneal injection of 0.3 mg of tamoxifen
at one year of age (Fig. 2A). Control mice were also injected with
0.3 mg of tamoxifen at one year of age. Mice were followed to two
years of age, at which time they were sacrificed and organs dissected for
further analyses and pathology.
To validate that Igf-1 gene recombination occurred in livers of
iLID mice, we assessed Igf-1 gene expression in livers of control and iLID
mice at sacrifice. Indeed, liver Igf-1 gene expression was significantly
reduced in iLID mice (Fig. 2B), leading to marked reductions in serum
IGF-1 levels (Fig. 2C) and a concomitant increase in serum GH levels
(Fig. 2D).
Age-dependent reductions in serum IGF-1 are associated with
increased liver weight, inflammation, and tumors
Depletion of liver Igf-1 at ‘middle age’ (~1 year old in a mouse
lifespan) in male iLID mice resulted in minor, but significant reductions
in body weight and gonadal fat pad weights at two years of age
(Table S3). Although a direct comparison between the LID cohort and
the iLID cohort cannot be made, we found that similar to the
congenital LID mice, reductions in serum IGF-1 in the iLID mice (in mid-
life) associated with significant reductions in kidney weight (Tables S2,
S3). Additionally, we found that relative heart weight increased in iLID
mice as compared to controls (while this was not significant in the LID
cohort).
Interestingly, as seen in the LID cohort, we found that iLID mice had
significantly increased relative liver weight (Fig. 3A). This was associated
with enhanced basal STAT5b phosphorylation (pSTAT5b) in livers of iLID
mice (P = 0.0015), possibly due to increased serum GH levels (Fig. 3B).
Furthermore, in accordance with previous publications using GH
transgenic mice (Miquet et al., 2013), we found that aged iLID
hepatocytes manifested a higher mean nuclear area when compared
to controls (Fig. 3C) with a shift to larger nuclear area in the nuclear size
distribution histogram.
Histological examination of liver sections revealed no increase in
hepatic lipid accumulation (data not shown). However, there was an
Table 1 End-of-life pathology of control and LID mice aged in the Nathan Shock










Neoplasm 4 (22.2%) 11 (68.8%) 12 (54.5%) 10 (58.8%)
Hepatocellular
carcinoma
1 (5.6%) 11 (68.8%)* 1 (4.5%) 4 (23.5)
Adenocarcinoma 3 0 1 3
Pituitary adenoma 0 0 2 1
Others 0 0 8 2
Non-neoplasm 14 5 10 7
Glomerulonephritis 6 1 8 2
Acidophilic mac.pn. 1 3 0 0
Others 3 0 1 2
Undetermined 4 1 1 3
*P < 0.05.
Fig. 2 Validation of the iLID mouse model. (A) Schematic presentation of the iLID
mouse model. (B) Hepatic Igf-1 gene expression at 2 years of age in iLID (n = 5)
and control (n = 5) mice following a single intraperitoneal injection of 0.3 mg of
tamoxifen at one year of age. (C) Serum IGF-1 levels at 2 years of age in iLID
(n = 30) and control (n = 20) mice. (D) Serum GH levels at 2 years of age in iLID
(n = 10) and control (n = 9) mice. Significance (*) was considered at P < 0.05.
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increased lymphoplasmacytic infiltrate in the portal regions in iLID mice,
while no inflammatory infiltrates were found in control mice at 2 years
of age (Fig. 3D). Additionally, the number of Iba1 (a marker of
macrophages) positive Kupffer cells significantly increased in iLID livers
(Fig. 3D). Likewise, F4/80 gene expression, a marker for macrophages,
was significantly higher in iLID livers (Fig. 3E). Consistent with an
increase in inflammatory infiltrate, gene expression of the cytokines IL-6
and TNFa was significantly increased in livers of iLID mice (Fig. 3E).
Moreover, the profile of cytokines in serum in mice showed marginally
higher levels in the iLIDs compared with controls, although no significant
differences were found (Fig. 3F, Table S4).
Macroscopic (PET scan) and histological examinations indicated an
increase in the incidence of hepatic tumors in the iLID mice at two years
of age (Fig. 3G). The incidence of hepatic tumors was 26% in control
and 42% in iLID mice, but did not reach significance. Extrahepatic tumor
incidence was 11% in control and 3% in iLID mice (Table S5). In a subset
Fig. 3 Inducible liver IGF-1-deficient mice show increased hepatic size, inflammation, and tumors. (A) Relative liver weight increased significantly in iLID mice (n = 36) as
compared to controls (n = 27). (B) iLID mice (n = 10) show increased basal STAT5b-phosphorylation (pSTAT5b) as compared to controls (n = 10, P = 0.0015).
Phosphorylated STAT5b levels were corrected to total STAT5b protein levels detected using the same membrane. (C) Nuclear size was evaluated in H&E-stained liver sections.
Fifty nuclei per section were measured and calibrated to an image scale bar using IMAGE J software. Distribution histogram shows nuclear size in control and iLID mice,
and insert bar graph shows mean nuclear size (N = 5 mice per group). (D) The fraction (%) of Iba1-positive Kuppfer cells counted in three sections per mouse from
control (n = 4) and iLID livers (n = 5 per group). iLID mice showed significant (P = 0.008) increase in Iba-1-positive cells in their livers. (E) Gene expression of markers
of inflammation in iLID and control livers (n > 7). (F) Serum cytokine levels in control and iLID mice (graph represents overall cytokines measured in all mice, see also
Table S4). (G) A representative PET scan image of iLID and control mice demonstrating increased uptake at the site of liver tumor.
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of control and iLID mice, PET scans were taken to localize tumors.
Figure 3G is a representative PET scan image of iLID and control mice
demonstrating increased FDG uptake at the site of the tumor. The
location of tumors as noted on PET scans was confirmed at the time of
sacrifice.
Age-dependent reductions in serum IGF-1 is associated with
increased oxidative stress in muscle and liver
We examined how reductions in serum IGF-1 levels during aging affect
reactive oxygen species (ROS) generation by assaying lipid peroxidation
(8-iso-prostaglandin F2-alpha (8-isoprostane)) in serum. This assay
requires large amounts of sera, and therefore, we had to pool samples.
Surprisingly, we found that iLID and control mice had comparable levels
of serum isoprostanes (Fig. 4A).
To better understand how hepatic Igf-1 gene deletion affected
oxidative stress resistance in liver and muscle, we used the OxyBlotTM
(OxyBlot Protein Oxidation Detection Kit S7150; Millipore, Billerica, MA,
USA) Protein Oxidation Detection method. This assay detects carbonyl
group-containing proteins that result from oxidative reactions with
ozone, oxides of nitrogen, or by metal-catalyzed oxidation. We found
that livers of iLID mice showed a 60% increase in oxidized proteins as
compared to controls, whereas muscles of iLID mice had a twofold
increase in oxidized proteins compared with controls (Fig. 4B).
Antioxidant defense includes induction of enzymatic machinery that
converts superoxide to hydrogen peroxide and molecular oxygen. The
Fig. 4 Inducible liver IGF-1-deficient mice show increased markers of oxidative stress. (A) Serum isoprostanes in control (n = 4) and iLID (n = 4) mice. (B) Carbonyl group-
contained proteins, detected by OxyBlotTM Protein Oxidation Detection Kit, increased in both livers and muscles of iLID mice compared with controls (n > 4 per group).
Relative density corresponds to whole lane. (C) Gene expression of markers of antioxidant defense enzymes in the livers and muscles of iLID (n = 5) and control (n = 5) mice.
(D) Peroxide-induced PARP cleavage in primary skin fibroblasts isolated from 2-year-old control (n = 4) and iLID mice (n = 5). Cultures were grown to 80% confluence
and treated with 400 µM peroxide for 8 and 24 h. PARP cleavage was detected by conventional Western immunoblotting. The levels of cleaved PARP were corrected to
both total PARP and b-actin, detected on the same blot.
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Nrf2 transcription factor is a master regulator of genes that are involved
in detoxification of harmful compounds such as glutathione peroxidase
(Gpx1) and catalase 2 enzymes. We therefore examined the expression
levels of Nrf2, GPX1, and catalase in liver and muscle of iLID and control
mice at 2 years of age. We found that there were no differences in Nrf2
gene expression (assessed by 2 sets of primers) in liver and muscle from
iLID mice as compared to controls (Fig. 4C). However, Gpx1 gene
expression significantly decreased (60% reduction) in the livers (but not
in muscle) of iLID mice, while no changes were detected in the
expression levels of catalase and superoxide dismutase in the livers
(Fig. 4C) or muscle between the groups.
Lastly, we assessed oxidative stress resistance of dermal fibroblasts
isolated at time of dissection from 2-year-old mice. Primary fibroblast
cultures were grown to 80% confluence and treated with peroxide
(400uM) for 8 or 24 h. As seen in Fig. 4D, peroxide induced significantly
more PARP cleavage in fibroblasts isolated from aged iLID mice as
compared to controls. This was evident when the intensity of the cleaved
PARP band was corrected to intact PARP or to the b-actin band
intensities. All together, these data indicate that iLID fibroblasts were
more sensitive to the cytotoxic effects of peroxide.
Reductions in serum IGF-1 during aging compromise skeletal
integrity
Femurs dissected from 2-year-old control and iLID mice were analyzed by
micro-CT (Table 2, Fig. 5A). We found that reductions in serum IGF-1
levels in iLID mice at one year resulted in significant loss of cortical bone
at two years. This was evident by reduced total cross-sectional area
(Tt.Ar), cortical bone area (Ct.Ar), cortical bone thickness (Ct.Th),
marrow area (Ma.Ar), and relative cortical bone area (RCA; Ct.Ar/Tt.Ar).
There were minor differences in trabecular bone traits. Specifically, iLID
mice showed reduced trabecular number when compared to controls
and an increase in trabecular thickness. However, overall bone volume
per total volume (%BV/TV) and bone mineral density (BMD) at the distal
femur were comparable between the groups (Table 2). Mechanical
properties of bones, dissected at 2 years, followed the morphological
properties obtained by micro-CT. Four-point bending testing showed
that iLID aged bones were mechanically inferior when compared to
controls (Table 2). As such, max load, stiffness, yield to fracture, and
postyield displacement were all significantly lower in iLID bones.
Bone mineral composition was measured by inductively coupled
plasma (ICP) assay (Table 2) in whole femurs dissected from 2-year-old
mice. We found that iLID mice had significantly lower ratio of Ca/Pi
when compared to controls, which was not reflected in tissue mineral
density (TMD) of cortical bone or in trabecular BMD.
To understand whether reductions in serum IGF-1 affected the
number of osteoprogenitors in the bone marrow, we established
osteoblast-like primary cultures. The number of alkaline positive colonies
after 14, 21, and 28 days in cultures was similar between controls and
iLID mice (Fig. 5B). Osteoclast primary cultures did not differ between
the groups (data not shown).
Serum osteocalcin, a marker of bone formation, did not differ
between control (29.8  6.9 ng mL1) and iLID mice (28.1  11.5
ng mL1) at two years of age. Another important hormone, which
regulates bone remodeling during aging is parathyroid hormone (PTH).
Elevations in PTH often associate with reduced bone mass. We found
that control and iLID mice show similar levels of PTH in serum (Fig. 5C).
Discussion
In this study, we have aged two animal cohorts of congenital liver IGF-1
deficiency (LID) and an inducible LID (iLID) and studied the role of the
GH/IGF-1 axis during aging. Although a direct comparison between the
2 cohorts cannot be made, we have revealed that reductions in serum
IGF-1 levels in both LID and iLID mice with concomitant increases in GH
associated with hepatomegaly, decreased kidney size and increased
incidence of hepatic tumors. In both models, we show that in face of low
levels of serum IGF-1, high levels of GH (even during aging only)
associate with increased pathology.
Survival studies with the LID mouse model have revealed that
congenital decreases in serum IGF-1 levels (LID) associated with
decreased lifespan in male mice and increased incidence of hepatic
tumors, likely reflecting lifelong increases in GH secretion. In contrast to
our results showing no change in female LID lifespan, Svensson et al.
(2011) observed increased median lifespan of female LID mice with no
significant difference in male LID lifespan compared with wild-type mice.
In that study, LID mice also showed reduced body weight similar to what
we observed. The reason(s) why our current results differ from Svensson
et al. is unclear, but could be related to the different genetic
backgrounds between the control and LID mice in our study. However,
it is also worth noting that the control mice in our study had robust
median lifespan of over 30 months, whereas the control mice in the
Svensson et al. study had median lifespans of 22-23 months, which is
shorter than expected for C57BL/6 strain. Thus, the LID female mice in
the Svensson study may have been protected against some life-
shortening stimulus. Likewise, in longevity studies (conducted at three
different locations) with mice homozygous for an insertion in the Igf1
Table 2 Bone morphology and mechanical properties of femurs from control and
iLID mice. Femurs dissected from 2-year-old mice were subjected first to micro-CT
and consequently 4-point bending tests and ICP
Control (n = 14) iLID (n = 12) P
Body weight, g 35.95  4.0 30.22  5.0 0.002
Cortical bone (femoral mid-diaphysis)
Total cross-sectional area (Tt.Ar),
mm2
2.38  0.31 1.94  0.24 0.000
Cortical bone area (Ct.Ar), mm2 0.84  0.07 0.60  0.08 0.000
Cortical bone thickness (Ct.Th),
mm
0.14  0.01 0.10  0.01 0.000
Marrow area (Ma.Ar), mm2 1.53  0.26 1.34  0.17 0.044
Relative cortical area 0.35  0.03 0.30  0.01 0.000
Polar moment of inertia (J0), mm4 0.55  0.11 0.35  0.07 0.000
Tissue Mineral Density, g/cc 1.46  0.07 1.47  0.05 0.696
Trabecular bone (distal femur)
Bone volume/Total volume (BV/
TV),%
3.62  2.48 2.27  1.49 0.137
Trabecular thickness (Tb.Th), mm 0.04  0.00 0.05  0.00 0.005
Trabecular number (Tb.N), 1/mm 0.83  0.51 0.43  0.26 0.036
Trabecular spacing (Tb.Sp), mm 0.37  0.12 0.32  0.09 0.354
Bone mineral density, g/cc 0.14  0.04 0.11  0.02 0.158
Mechanical properties (4-point bending assay)
Max load, N 26.67  4.10 13.27  4.49 0.000
Stiffness, N/mm 115.87  30.47 81.19  37.23 0.017
Work to fracture, Nmm 5.83  3.16 1.92  0.78 0.003
Postyield displacement, mm 0.256  0.125 0.100  0.036 0.002
Bone mineral compositions (ICP)
Calcium (Ca2+), ppm 37.25  0.96 37.72  1.00 0.250
Phosphate (Pi), ppm 17.75  0.44 18.17  0.50 0.035
Pi/Ca2+ ratio 0.47  0.00 0.48  0.00 0.005
Ca2+/Pi ratio 2.09  0.01 2.07  0.00 0.005
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gene, which leads to significant reductions in IGF-1 levels, it was found
that the maximum lifespan significantly increased and age-specific
mortality rates were reduced in the IGF-1-deficient mice (Lorenzini et al.,
2013). However, mean lifespan was increased in female IGF-1-deficient
animals in only one site and early life mortality was noted in one cohort
of IGF-1-deficient mice, indicating that reductions in IGF-1 alone are
insufficient to increase both mean and maximal lifespan in mice.
Using the iLID model, we induced IGF-1 deficiency after the critical
phase of growth and development and followed the mice up to two
years of age. We have found that in iLID mice reductions in serum IGF-1
and concomitant increases in GH levels during aging associated with
increased liver weight, systemic and liver inflammation, increased
oxidative stress, and increased incidence of hepatic tumors, although
this did not reach significance. We postulate that this phenotype relates
to the unopposed action of high GH levels on hepatocytes, as evidenced
by the increased basal STAT5b phosphorylation in livers from iLID mice.
Possible increase in hepatic GH action was also evident by increase in
hepatocyte nuclear size in the iLID mice. These data are in accordance
with previous observations using the GH transgenic mice (Miquet et al.,
2013), which also manifested increased hepatocellular nuclear size.
Using the iLID model, we show, for the first time, that elevations in GH
late in life have detrimental effects on the liver.
Inducible liver IGF-1-deficient mice showed increased macrophage
infiltration and other cellular infiltrate in the liver. GH has been
implicated in recruitment of inflammatory cells (Franceschi et al.,
2005), suggesting that the excess of GH action in the liver of the iLID
mice triggered hepatic inflammation. In GH-deficient (GHD) patients,
who exhibit major reductions in serum IGF-1, there is significantly
impairment of natural killer (NK) cell activity, both unstimulated and
stimulated by INFc or IL-2. Similarly, NK cell concentration and the
proportion of NK cells (CD16+) were reduced in GHD patients compared
with controls (Sneppen et al., 2002). On the other hand, an increase in
T-cell activity and a decrease in B-cell activity have been demonstrated in
a very large cohort of patients with acromegaly, with high levels of
serum GH and IGF-1 (Colao et al., 2002). However, despite this valuable
information, these studies demonstrate conditions in which the changes
in GH and IGF-1 paralleled, namely both decreased as seen in states of
GHD, or increased as seen in acromegaly. Thus, the relative contribution
of each hormone to the inflammatory phenotype is hard to be
determined. In the iLID model, we show that in the face of low levels
of serum IGF-1, high levels of GH in serum associate with increased
inflammation. These results strongly suggest causality between GH
elevations and hepatic inflammation.
The aforementioned increases in hepatic inflammation, oxidative
stress, and GHR activation in livers of the iLID mice were associated with
increased incidence of hepatic tumors, although this did not reach
significance. In LID mice, however, where serum IGF-1 decreased
throughout lifespan, we have shown a significant increase in liver
tumors. We attribute the increase in hepatic tumor incidence to the high
levels of GH in the LID and iLID mice. Our findings are in line with
previous observations showing a link between increased GH signaling
and hepatic tumors (Baik et al., 2011; Mueller et al., 2011; Miquet
et al., 2013). Accordingly, Sonntag et al. (2005) has shown that
reductions in both GH and IGF-1 during adulthood and aging, reduced
neoplastic disease, nephropathy, and total disease burden. Unfortu-
nately, we did not perform survival studies in the iLID cohort, and thus,
we cannot conclude that the findings above contributed to the overall
mortality of the iLID mice.
Aged iLID mice demonstrated increased oxidative stress in liver and
muscle. Thiswas evident by significant increases in tissue levels of oxidative
proteins in both livers and muscles of iLID mice as compared to controls.
Our findings are consistent with recent studies demonstrating increased
cellular oxidative stress in aged animals with adult onset IGF-1 deficiency
(Bailey-Downs et al., 2012). In that study, cultured aorta segments of IGF-
1-deficient mice treated with a panel of oxidative stressors showed
attenuation in Nrf2-driven genes, leading to endothelial dysfunction,
increased oxidative stress, and apoptosis. In line with these data, it has
been shown that IGF-1 can oppose oxidative stress-induced damage in the
vasculature by up-regulating glutathione peroxidase (Higashi et al.,
2013). Consistent with this evidence, we have found that fibroblasts
isolated from aged iLID mice show increased sensitivity to peroxide, as
reflected by increased levels of cleaved PARP. We postulate that the
increased sensitivity to oxidative stress is due to increases in serum GH
levels during aging. It has been previously shown that fibroblast cultures
from aged GH-deficient Snell, Ames, and GHRKO mice were resistant to
the cytotoxic effects of peroxide and paraquat (Murakami et al., 2003;
Salmon et al., 2005). In Snell dwarfs, resistance to peroxide and paraquat
was associated with increased catalase activity (Page et al., 2009).
Lastly, we studied bone loss, another physiological hallmark of aging.
In humans, the physiological decline in GH and IGF-1 levels is linked to
osteoporosis. Using the iLID model, we were able to delineate the role of
the GH/IGF-1 axis in skeletal aging, without the confounding effects of
Fig. 5 Inducible liver IGF-1-deficient mice
exhibit impaired skeletal integrity during
aging without changes in bone marrow
osteoprogenitor number or serum PTH
levels. (A) A representative image of bones
from control and iLID mice injected with
tamoxifen (0.3 mg) at 1 year of age and
dissected at 2 years. (B) Primary osteoblast-
like cultures of bone marrow mesenchymal
stem cells dissected at 2 years of age.
Cultures maintained in differentiation
media for 14, 21 and 28 days and the
density of alkaline phosphatase-positive
colonies was calculated, (control n = 5, iLID
n = 7). (C) Serum PTH levels in control
(n = 18) and iLID (n = 26) mice at 2 years
of age.
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this axis on the growing skeleton. In our previous studies characterizing
the LID mice during development, we found that reduced serum levels of
IGF-1 in LID mice were associated with the development of slender
bones (Elis et al., 2010a). This slender phenotype developed at an early
pubertal age and persisted to 52 weeks, affecting mostly radial bone
growth and minimally affecting linear growth. In a subsequent study, we
performed skeletal characterization of the iLID mice, where depletion of
serum IGF-1 was induced at 4 (prepuberty) and at 8 (postpuberty) weeks
of age (Courtland et al., 2011). We showed that depletion of serum IGF-
1 during growth compromised peak bone mass. Here, we depleted
serum IGF-1 during advanced adulthood (iLID), when bone loss becomes
more prevalent, and we showed that reductions in serum IGF-1 during
aging impaired bone integrity. Taken together, data from both studies
show that depletion of serum IGF-1 during growth affects skeletal
development and peak bone accrual, while during aging, serum IGF-1
appears to play protective roles on the skeleton and its reductions affect
mainly the cortical compartment.
In conclusion, animal and human studies have revealed major roles of
the GH/IGF-1 axis in the regulation of growth, development, and organ
function. As such, decline in these two pleiotropic hormones during aging
was shown to associate with organ dysfunction. On the other hand, high/
normal levels of GH/IGF-1 during aging have been associated with the
development of neoplastic disease in both human and animals, and
complete lifelong suppression of GH signaling in rodents produces robust
extension of longevity. Thus, the involvement of this axis in the aging
phenotype remains controversial, and the relative contribution of each
hormone (GH or IGF-1) to age-related pathology is still doubtful and may
be tissue specific. We have shown here that low circulating levels of IGF-1
coupledwith high levels of GH during aging, associate with hepatomegaly
and increased hepatic pathology in both LID and iLID models and with
reduced longevity of LIDmales. At the same time, we show that elevations
in GH were insufficient to protect against bone loss during aging.
Methods
Animals
The iLID model (C57BL/6 background) has been described previously
(Courtland et al., 2011). Male mice used in this study were given
unrestricted access to water and food and housed to a maximum of 5
per cage under a 12 h light/dark cycle. Animal care and maintenance
were provided through the NYU AAALAC Accredited Animal Facility. All
procedures approved by the Institutional Animal Care and Use
Committee of the NYU. See additional details in supplemental methods.
Lifespan studies of LID mice on a mixed genetic background (C57BL/
6, FVB/N, and 129sv) were conducted in the Nathan Shock Center at
Texas Health Center, San Antonio (UTHSCSA). Food intake was also
recorded. Pathological lesions were identified and graded for severity as
previously described (Ikeno et al., 2005). See additional details in
Methods S1.
Animal care and maintenance were provided through the UTHSCSA
AAALAC Accredited Animal Facility. All procedures approved by the
Institutional Animal Care and Use Committee of the UTHSCSA.
Hormone measurements
Mice were bled between 7 and 9 AM via the mandibular vein before
sacrifice. Serum samples were collected in a fed state at 22-24 months
of age. Serum IGF-1 levels were measured by RIA (American Laboratory
Products Company, Inc., Salem, NH, USA). Serum GH levels were
determined using commercial ELISA kit (Millipore, Temecula, CA, USA).
Serum osteocalcin levels were measured by ELISA (Millipore Inc). Serum
PTH levels were determined by mouse PTH ELISA (Immutopics Inc., San
Clemente, CA, USA).
Serum isoprostanes
8-iso PGF2a levels were measured by GC/MS as described by Roberts and
Morrow (Roberts & Morrow, 2000). The 8-iso PGF2a concentrations are
computed using either peak area or peak height, that is, area of sample/
area of standard x ng standard added = ng 8-iso PGF2a in the sample.
Data were normalized to plasma volume.
Serum cytokine assay
Serum cytokine levels were assessed usingmouse proinflammatory 7-plex
ultra-sensitive kit (K15013C-1, Meso Scale Discovery) according to the
manufacturer’s instructions. Plates were read on a SECTOR plate reader.
Gene expression
Total RNA was extracted from tissues using TRIzol (Invitrogen, Carlsbad,
CA). RNA samples (1 lg) were reverse-transcribed using oligo-(dT)
primers (Invitrogen), and quantitative real-time PCR was performed
following the manufacturer’s instructions using the QuantiTectTM SYBR
green PCR kit (Qiagen, Valencia, CA, USA) on an ABI PRISM 7900HT
sequence detection system (Applied Biosystems, Foster City, CA, USA).
Transcript levels were assayed 3 times in each sample, and the fold-
change ratios between experimental and control samples were calcu-
lated. We used three housekeeping genes; b-actin, GAPDH, and 18S. As
no differences were found when data corrected to each housekeeping
gene, we present data obtained after correction to 18S. For primer
sequences, refer to Table S6.
Tissue oxidative stress levels
oxidative stress was measured using OxyBlot Protein Oxidation Detection
Kit (S7150, Millipore). Proteins extracts obtained in RIPA buffer (25 mM
Tris-HCl pH 7.6, 150 mM NaCl, 1% Triton X-100, 1% sodium deoxy-
cholate, 0.1% SDS). 20 µg of protein extracts from liver and muscles of
control and iLID mice were analyzed according to the manufacturer’s
instructions.
Primary fibroblast cultures
One centimeter of mouse tail was rinsed in 70% ethanol three times and
consequently with PBS to remove excess alcohol. Tails were minced with
a sterile scalpel (#22 Blade, Fisher, 08-918-5C; Scalpel Handle, 08-917-5)
and digested overnight with collagenase (400 U mL1, Gibco, 17101-
015). Cells were then passed through a sterile nylon netting (40-lm
nylon mesh, BD Falcon, 25-2340 with Falcon 50 mL culture tubes, 35-
2098) to remove small pieces of skin and hair. Cells were counted and
seeded at 0.25 9 106 cells in 6 mL complete DMEM in a T-25 tissue
culture flask. To evaluate oxidative stress resistance, cells were seeded in
6-well plates and treated with 400 lM peroxide for 8 or 24 h. At the end
of treatment, cells were harvested in RIPA buffer (25 mM Tris-HCl pH
7.6, 150 mM NaCl, 1% Triton X-100, 1% sodium deoxycholate, 0.1%
SDS). Twenty microgram of total protein extracts was run on 4-10%
SDS-PAGE, and PARP (#9542, Cell Signaling, Danvers, MA, USA)
cleavage was detected by immunoblot. The levels of cleaved PARP were
Aging with low serum IGF-1, Z. Gong et al. 415
ª 2013 The Authors. Aging Cell published by the Anatomical Society and John Wiley & Sons Ltd.
corrected to both total PARP and b-actin (Cell Signaling, #4970),
detected on the same blot.
Tissue protein extraction and detection
Liver proteins were obtained from 50 mg liver tissue homogenized in
RIPA buffer (25 mM Tris-HCl pH 7.6, 150 mM NaCl, 1% Triton X-100,
1% sodium deoxycholate, 0.1% SDS). Twenty microgram of total
protein extracts of control and iLID mice were run on 4-20% SDS-PAGE.
Membranes were blocked in 5% nonfat dry milk and subjected to
immunoblot. Phospho-STAT5b (Cell Signaling, CAT # 9359) and total
STAT5b (Cell Signaling, CAT# 9363) were diluted in TBS-T (1:1000) and
detected according to manufacturer’s instructions. b-actin (Cell Signal-
ing, CAT# 4970) was used as a loading control. Levels of phosphorylated
STAT5b were corrected to total STAT5b, using a stripped membrane.
Quantification was performed by FUJIFilm LAS3000, and 10 mice from
each group were used for the quantification.
Primary osteoblast-like cultures
Bonemarrow cells were flushed out from femurs using a 26-gauge needle
and collected in aMEM culture medium and drawn through 18-gauge
needle to achieve single-cell suspension. Cells were thenwashed in aMEM
culture medium and cultured in aMEM supplemented with 10% heat-
inactivated FBS with b-glycerophosphate (10 mM) and ascorbic acid
(50 mM). Cellular alkaline phosphatase activity was determined using a
para-nitrophenol phosphate-based colorimetric assay. Cultures were
carried out for different time points as indicated. Alkaline phosphate
(ALP) stainingwas performed using an Alkaline Phosphatase kit according
to the manufacturer’s instructions (Sigma-Aldrich, St. Louis, MO, USA).
Histology
Tissues were fixed in 10% buffered formalin phosphate (Fisher Scientific)
and embedded in paraffin. Immunohistochemistry with rabbit anti-mouse
Iba1 (Wako Chemicals, VA) was performed in 5 um sections of paraffin-
embedded livers. Three sections were analyzed per mouse, where the
percentage of Iba-1-positive cells was calculated per each section. Nuclear
size was evaluated in H&E-stained liver sections. We analyzed one section
per mouse and 5 mice per group that were blinded to the observer. Fifty
nuclei per section were measured and calibrated to an image scale bar
using IMAGE J software (National Institutes of Health, Bethesda, MD, USA).
Micro-CT
Femoral bone morphology at the mid-diaphysis, and trabecular bone
volume fraction and micro-architecture in the distal femoral metaphysis
were assessed as previously described (Elis et al., 2010a,b) and according




Positron emission tomography scan was performed in a Micro-Positron
Emission Tomography/Computed Tomography (l-PET/CT) (Siemens, TN,
USA) using 18F-fluorodeoxyglucose (18F-FDG). The animals were fasted
for 8-10 h before undergoing PET. They were anesthetized using
1 L min1 of 2% isoflurane in 100% oxygen and injected intravenously
with 10 MBq 18F-FDG. After 1 h had been allowed for clearance of
nonspecifically bound tracer, the animals received an intraperitoneal
injection of 30 lL of a mixture of ketamine and xylazine (80 and
20 mg mL1, respectively) and subsequently imaged. Static acquisition
was performed for 30 min.
Mechanical testing by 4-point bending assay
Mouse femora from 2-year-old control and iLID mice were tested to
failure by 4-point bending using a servohydraulic materials testing
system (Bose, Canton, MA, USA). This test measures whole-bone
stiffness, maximum load, postyield deflection and work to failure.
Femora were placed with the anterior surface down on two lower
supports. The two lower and two upper supports were set apart by 6.35
and 2.2 mm, respectively. Loading was centered over the mid-shaft, at a
displacement of 0.05 mm s1 until failure.
Inductively coupled plasma
Thermo Jarrell Ash Trace Scan Advantage was used to determine bone
mineral compositions (Ca,P). 10 mg of bone mineral powder was
dissolved in 17% HCl and made up to 100 mL in a volumetric flask with
double distilled water. Appropriate standard solutions for Ca (0, 1 and
50 ppm) and P (0, 1 and 30 ppm) were prepared from 100 ppm
standard solutions of the respective elements (Fisher Scientific). The
specimen in solution and standard solutions was pumped through argon
plasma excited by 2 kW 27.12 MHz radio frequency generator. The
concentrations of each element were determined using their character-
istic wavelengths (Ca: 317.9A˚, P: 213.6 A˚).
Statistical analysis
For survival studies of the LID mice and end-of-life pathology, total
frequency and grade of lesions were compared between genotypes
using a chi-square test. When the expected frequencies were too small
for the chi-square test, the data were analyzed using Fisher’s exact test.
The Kaplan–Meier survival curves for fatal neoplastic lesions and
adenocarcinoma were analyzed using a log-rank test (Lawless 1990).
All differences in mean serum hormone levels, organ weights, and
growth between controls and iLID mice were assessed by T-test. Values
are presented as the mean  SEM, and P < 0.05 was considered
statistically significant. All micro-CT measurements, mechanical tests,
and ICP data are presented as the mean  SD.
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